Once clinical studies have demonstrated the effectiveness and safety of a new intervention in the area of health assistance, the key question for payers is what benefits this could effectively offer patients in real conditions. How is the clinical improvement perceived by the patients? Are the patients who are treated with the drug in actual practice the same as those included in the clinical studies?
To respond effectively it is necessary to resort to Outcome Research, which has the goal of defining and carrying out health economic studies to support national and/or local Health Technology Assessment (HTA) activities.
Through direct exploration, we help customers understand what drives the payers’ decision-making process. We express and test a clear Value Story of the product/portfolio, producing the relevant evidence and support tools.